Literature DB >> 26976762

Regulation of TBK1 activity by Optineurin contributes to cell cycle-dependent expression of the interferon pathway.

Robert Weil1, Emmanuel Laplantine1, Pierre Génin2.   

Abstract

The innate immune system has evolved to detect and neutralize viral invasions. Triggering of this defense mechanism relies on the production and secretion of soluble factors that stimulate intracellular antiviral defense mechanisms. The Tank Binding Kinase 1 (TBK1) is a serine/threonine kinase in the innate immune signaling pathways including the antiviral response and the host defense against cytosolic infection by bacteries. Given the critical roles of TBK1, important regulatory mechanisms are required to regulate its activity. Among these, Optineurin (Optn) was shown to negatively regulate the interferon response, in addition to its important role in membrane trafficking, protein secretion, autophagy and cell division. As Optn does not carry any enzymatic activity, its functions depend on its precise subcellular localization and its interaction with other proteins, especially with components of the innate immune pathway. This review highlights advances in our understanding of Optn mechanisms of action with focus on the relationships between Optn and TBK1 and their implication in host defense against pathogens. Specifically, how the antiviral immune system is controlled during the cell cycle by the Optn/TBK1 axis and the physiological consequences of this regulatory mechanism are described. This review may serve to a better understanding of the relationships between the different functions of Optn, including those related to immune responses and its associated pathologies such as primary open-angle glaucoma, amyotrophic lateral sclerosis and Paget's disease of bone.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiviral host defence; Autophagy; Cell cycle regulation; Innate immunity

Mesh:

Substances:

Year:  2016        PMID: 26976762     DOI: 10.1016/j.cytogfr.2016.03.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  8 in total

1.  The TBK1-OPTN Axis Mediates Crosstalk Between Mitophagy and the Innate Immune Response: A Potential Therapeutic Target for Neurodegenerative Diseases.

Authors:  Lu He; Linxi Chen; Lanfang Li
Journal:  Neurosci Bull       Date:  2017-03-07       Impact factor: 5.203

2.  USP19 (ubiquitin specific peptidase 19) promotes TBK1 (TANK-binding kinase 1) degradation via chaperone-mediated autophagy.

Authors:  Xibao Zhao; Qianqian Di; Juan Yu; Jiazheng Quan; Yue Xiao; Huihui Zhu; Hongrui Li; Jing Ling; Weilin Chen
Journal:  Autophagy       Date:  2021-08-26       Impact factor: 13.391

Review 3.  Targeting TANK-binding kinase 1 (TBK1) in cancer.

Authors:  Or-Yam Revach; Shuming Liu; Russell W Jenkins
Journal:  Expert Opin Ther Targets       Date:  2020-10-05       Impact factor: 6.902

Review 4.  Viral Evasion Strategies in Type I IFN Signaling - A Summary of Recent Developments.

Authors:  Katharina S Schulz; Karen L Mossman
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

Review 5.  Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer.

Authors:  Robert Weil; Emmanuel Laplantine; Shannel Curic; Pierre Génin
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

Review 6.  The role of TBK1 in cancer pathogenesis and anticancer immunity.

Authors:  Austin P Runde; Ryan Mack; Peter Breslin S J; Jiwang Zhang
Journal:  J Exp Clin Cancer Res       Date:  2022-04-09

Review 7.  Evasion of interferon-mediated immune response by arteriviruses.

Authors:  Zhijie Jian; Rui Ma; Ling Zhu; Huidan Deng; Fengqin Li; Jun Zhao; Lishuang Deng; Siyuan Lai; Xiangang Sun; Huaqiao Tang; Zhiwen Xu
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

Review 8.  The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications.

Authors:  Wenting Guo; Tijs Vandoorne; Jolien Steyaert; Kim A Staats; Ludo Van Den Bosch
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.